Your browser doesn't support javascript.
loading
Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival.
Johnson, G A; Mannel, R; Khalifa, M; Walker, J L; Wren, M; Min, K W; Benbrook, D M.
Afiliação
  • Johnson GA; Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City 73190, USA.
Gynecol Oncol ; 65(3): 425-9, 1997 Jun.
Article em En | MEDLINE | ID: mdl-9190969
ABSTRACT

OBJECTIVE:

To evaluate the level of epidermal growth factor receptor (EGF-R) expression in vulvar malignancies and to determine if a correlation exists between EGF-R levels and metastasis or patient survival.

METHODS:

All patients with a diagnosis of invasive squamous cell carcinoma of the vulva who were treated at our institution with a primary radical vulvectomy and inguinal lymph node dissection from 1983 to 1993 were eligible for the study. Sixty-one patients with available tissue blocks of benign vulvar epithelium, the primary malignant vulvar lesion, and groin node metastasis (when positive) were included in the study. Semiquantitative EGF-R expression was determined in a blinded fashion utilizing immunohistochemical staining of appropriate tissue samples. Survival was calculated utilizing Kaplan-Meier life table analysis based upon disease-free survival.

RESULTS:

A significant increase (P < 0.001) in mean EGF-R levels was demonstrated in the primary tumor (67%) versus benign vulvar epithelium (31%). In the 14 patients with lymph node metastasis, the mean EGF-R level in the primary tumor was 65% versus 88% in the metastatic lesion (P < 0.001). The likelihood of lymph node metastasis was elevated in those patients with a benign tissue EGF-R level > or =40% (P < 0.03) and in those patients with a primary tumor EGF-R level > or =90% (P < 0.025). Life table analysis revealed a cumulative disease-free survival of 45% for all patients. Disease-free survival in those patients with EGF-R levels > or =90% in the primary tumor was 25%, contrasting with a disease-free survival of 54% in those patients with EGF-R levels <90% (P < 0.05).

CONCLUSIONS:

There is a progressive increase in EGF-R expression from benign vulvar epithelium to primary malignant tissue to metastatic lesions within the same patient. Increased expression of EGF-R in the primary vulvar malignancy is significantly associated with lymph node metastasis and decreased patient survival. Increased expression of EGF-R in histologically benign vulvar epithelium has a significant association with lymph node metastasis and may predict decreased patient survival.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Vulvares / Carcinoma de Células Escamosas / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 1997 Tipo de documento: Article País de afiliação: Estados Unidos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Vulvares / Carcinoma de Células Escamosas / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 1997 Tipo de documento: Article País de afiliação: Estados Unidos